Morgan Stanley Portfolio holdings
Morgan Stanley is a financial services company with divisions for institutional services, wealth management and investment management. Its institutional arm advises large institutions on strategy and raising capital, its wealth arm serves individuals and family offices and runs the E-Trade self-directed investing service, and its investment arm offers hedge fund, real estate and infrastructure strategies as well as private equity and private credit. It was founded in 1935 by Harold Stanley and Henry Sturgis Morgan, who was J.P. Morgan's grandson, both leaving J.P. Morgan & Co., after the Glass-Steagall Act forced commercial and investment banking apart. In 1997 it merged with Dean Witter Discover, the financial services business Sears had spun off, and it went back to the Morgan Stanley name in 2001. In 2009 its wealth business was merged with Citigroup's Smith Barney, and in 2012 Morgan Stanley bought a larger share of that venture from Citigroup. Morgan Stanley later bought E-Trade in 2020 and Eaton Vance in 2021.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.02% |
| 2 | Technology | 24.63% |
| 3 | Financials | 9.78% |
| 4 | Healthcare | 7.32% |
| 5 | Industrials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2351
BlackRock Resources & Commodities Strategy Trust
BCX
$910M
| $44.7M | ﹤0.01% |
3,951,148
+196,133
| +5% | +$2.36M |
2013 Q2
52 quarters
|
|
2352
Goldman Sachs BDC
GSBD
$1B
| $44.7M | ﹤0.01% |
4,713,836
+1,083,863
| +30% | +$10.1M |
2015 Q1
45 quarters
|
|
2353
Fortuna Silver Mines
FSM
$2.58B
| $44.7M | ﹤0.01% |
5,286,739
-973,014
| -16% | -$9.43M |
2013 Q2
52 quarters
|
|
2354
Global X Russell 2000 Covered Call ETF
RYLD
$1.3B
| $44.7M | ﹤0.01% |
2,792,826
+188,526
| +7% | +$2.93M |
2021 Q4
18 quarters
|
|
2355
First Trust Dorsey Wright International Focus 5 ETF
IFV
$209M
| $44.6M | ﹤0.01% |
1,655,802
+385,027
| +30% | +$10.5M |
2014 Q3
47 quarters
|
|
2356
Acadian Asset Management
AAMI
$3.13B
| $44.6M | ﹤0.01% |
623,422
+85,779
| +16% | +$5.98M |
2014 Q4
46 quarters
|
|
2357
Nuveen Preferred & Income Opportunities Fund
JPC
$2.6B
| $44.6M | ﹤0.01% |
5,655,933
+213,041
| +4% | +$1.68M |
2013 Q2
52 quarters
|
|
2358
Compañía de Minas Buenaventura
BVN
$6.68B
| $44.6M | ﹤0.01% |
1,521,595
+105,152
| +7% | +$3.57M |
2013 Q2
52 quarters
|
|
2359
CleanSpark
CLSK
$1.91B
| $44.5M | ﹤0.01% |
3,061,702
-3,697,802
| -55% | -$52.2M |
2020 Q1
25 quarters
|
|
2360
iShares North American Natural Resources ETF
IGE
$836M
| $44.5M | ﹤0.01% |
792,391
-318,878
| -29% | -$19.3M |
2013 Q2
52 quarters
|
|
2361
MGE Energy Inc
MGEE
$2.79B
| $44.5M | ﹤0.01% |
545,468
+239,075
| +78% | +$18.5M |
2013 Q2
52 quarters
|
|
2362
Sabra Healthcare REIT
SBRA
$5.09B
| $44.5M | ﹤0.01% |
2,279,604
+37,361
| +2% | +$741K |
2013 Q2
52 quarters
|
|
2363
ProPetro Holding
PUMP
$944M
| $44.4M | ﹤0.01% |
3,097,319
-78,747
| -2% | -$1.22M |
2017 Q2
36 quarters
|
|
2364
Spyre Therapeutics
SYRE
$8.92B
| $44.4M | ﹤0.01% |
499,963
+253,244
| +103% | +$18.5M |
2016 Q3
39 quarters
|
|
2365
First Financial Bancorp
FFBC
$3.41B
| $44.4M | ﹤0.01% |
1,311,735
+72,565
| +6% | +$2.22M |
2013 Q2
52 quarters
|
|
2366
Progyny
PGNY
$2.22B
| $44.3M | ﹤0.01% |
1,535,897
-751,720
| -33% | -$16.8M |
2019 Q4
26 quarters
|
|
2367
Ultragenyx Pharmaceutical
RARE
$1.59B
| $44.2M | ﹤0.01% |
1,324,805
-175,723
| -12% | -$4.36M |
2014 Q1
49 quarters
|
|
2368
Cohen & Steers Duration Preferred & Income Fund
LDP
$558M
| $44.2M | ﹤0.01% |
2,089,803
+48,867
| +2% | +$1.01M |
2013 Q2
52 quarters
|
|
2369
Invesco S&P 500 Equal Weight Health Care ETF
RSPH
$966M
| $44.2M | ﹤0.01% |
1,332,257
+654,849
| +97% | +$20.4M |
2013 Q2
52 quarters
|
|
2370
X4 Pharmaceuticals
XFOR
$325M
| $44.2M | ﹤0.01% |
9,461,279
-5,713
| -0.1% | -$23.4K |
2017 Q4
34 quarters
|
|
2371
iShares Convertible Bond ETF
ICVT
$7.58B
| $44.1M | ﹤0.01% |
362,461
+28,391
| +8% | +$3.29M |
2018 Q3
31 quarters
|
|
2372
AXT Inc
AXTI
$3.38B
| $44.1M | ﹤0.01% |
611,974
-831,660
| -58% | -$74.9M |
2013 Q2
52 quarters
|
|
2373
State Street SPDR Bloomberg 3-12 Month T-Bill ETF
BILS
$3.96B
| $44.1M | ﹤0.01% |
443,633
-26,308
| -6% | -$2.61M |
2022 Q4
14 quarters
|
|
2374
Galicia Financial Group
GGAL
$5.2B
| $44.1M | ﹤0.01% |
880,638
-520,730
| -37% | -$24.5M |
2013 Q2
52 quarters
|
|
2375
Hess Midstream
HESM
$4.22B
| $43.9M | ﹤0.01% |
1,167,570
-553,321
| -32% | -$21.3M |
2017 Q2
36 quarters
|
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 425 new, 3,807 increased, 3,215 reduced and 302 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 425 new positions and closed 302 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.